Activists and physicians have worked hard to end punitive responses to addiction and recast it as a chronic illness treatable, in part, with medications like buprenorphine. But the "chronic illness" paradigm raises new questions: How to avoid the stigma and social limitations associated with chronic illness? How to prevent pharmaceutical industry influence over medication assisted treatment (MAT)? This symposium brings together leading scholars of addiction, pharmaceutical, and chronic illness to explore the promises and perils of applying this paradigm to drug dependence and addiction.
UB Medical Campus, Jacobs School of Medicine and Biomedical Sciences,
Buffalo, New York, USA
This symposium is free and open to the public, please register online.